Biocon Gets A New Group CEO As Aflibercept Approval Arrives

Peter Bains Named As New Chief; Yesafili Biosimilar Is Europe’s First Eylea Rival

 
• By David Wallace
  
CEO 3d rendering
Biocon has named Peter Bains as group CEO

More from Leadership

More from Generics Bulletin